Eric Sauter, COO/Co-Founder, brings over 10 years of medical device development experience in the cardiac EP field. Eric started his career as employee #1 of Farapulse and has since held R&D roles at Abbott, Teleflex, Access Point Technologies, and Freudenberg.  Mr. Sauter has significant experience in developing energy-based therapies in the cardiac EP space. He has participated in “bench to bedside” hands-on support for two First-In-Human clinical studies, Farapulse IMPACT and Acutus PFA-CE, advancing technologies from the early concept phase through preclinical evaluations and successful clinical use. Mr. Sauter has extensive experience in cleanroom manufacturing, operations, device controls, quality management, and design assurance testing. Mr. Sauter holds a B.S.E. in Chemical Engineering from University of Iowa.

Jay Kelley, Chief Marketing Officer, brings over 20 years of medical device R&D and commercialization experience, primarily focused in the cardiac EP field. He has held a variety of leadership roles at Medtronic and J&J (Biosense Webster) as well as several startups, with functional expertise ranging from Advanced R&D to Marketing, Clinical Affairs, and Training/Education. Jay’s start-up experience includes Ablation Frontiers (acquired by Medtronic for up to $225 million) and Filmetrics (acquired by KLA). He holds a B.S. in Bioengineering from UCSD, M.S. in Biomedical Engineering from Keck Graduate Institute, and an M.B.A. from Drucker School of Management at Claremont Graduate University.

Charles Yang, SVP QA/RA, is a seasoned executive with over 20 years of medical device regulatory and quality experience. He’s helped several cardiovascular companies secure regulatory approvals in the U.S., Europe, Japan, Canada, Australia, and other countries and has successfully supported FDA and other regulatory body audits. He was previously Co-founder of RC Medical, an incubator which spun out multiple companies. He was also a founder of an OEM manufacturer of medical devices. Previously, Charles worked with Blockade Medical (acquired by Balt in 2016), Ablation Frontiers (acquired by Medtronic for up to $225 million), and Edwards Lifesciences. Charles received a B.S. in Bioengineering at UCSD.

TJ Strang, VP Engineering, is an engineering leader who brings over 20 years of product development experience in the medical device industry, primarily in the device-based treatment of cardiac arrythmias. He led product development for implantable cardiac leads for St. Jude Medical/Abbott, and recently led product development for cardiac mapping and ablation catheters at Acutus Medical. In addition to performing technical due diligence at St. Jude Medical for various acquisition targets, his direct start-up experience includes   Bacchus Vascular   (acquired by Covidien).   Mr. Strang  holds a B.S. in  Chemical Engineering from Brigham Young University and an M.B.A. from UCLA Anderson School of Business.